Salient Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-28,605
| Closed | -$2.35M | – | 131 |
|
|
2017
Q2 | $2.35M | Sell |
28,605
-19,800
| -41% | -$1.63M | 0.05% | 93 |
|
|
2017
Q1 | $4.07M | Sell |
48,405
-4,330
| -8% | -$364K | 0.07% | 79 |
|
|
2016
Q4 | $3.88M | Sell |
52,735
-111,698
| -68% | -$8.22M | 0.07% | 78 |
|
|
2016
Q3 | $13.2M | Sell |
164,433
-8,981
| -5% | -$721K | 0.27% | 40 |
|
|
2016
Q2 | $13.7M | Sell |
173,414
-6,241
| -3% | -$491K | 0.3% | 40 |
|
|
2016
Q1 | $12.9M | Buy |
179,655
+26,512
| +17% | +$1.91M | 0.37% | 43 |
|
|
2015
Q4 | $12.9M | Buy |
153,143
+12,678
| +9% | +$1.07M | 0.34% | 44 |
|
|
2015
Q3 | $11.8M | Buy |
140,465
+6,101
| +5% | +$511K | 0.29% | 46 |
|
|
2015
Q2 | $11.2M | Buy |
134,364
+4,250
| +3% | +$355K | 0.21% | 52 |
|
|
2015
Q1 | $9.45M | Buy |
130,114
+17,912
| +16% | +$1.3M | 0.18% | 55 |
|
|
2014
Q4 | $7.74M | Buy |
112,202
+17,894
| +19% | +$1.23M | 0.15% | 60 |
|
|
2014
Q3 | $6.12M | Buy |
94,308
+20,926
| +29% | +$1.36M | 0.11% | 72 |
|
|
2014
Q2 | $4.56M | Buy |
73,382
+22,551
| +44% | +$1.4M | 0.1% | 74 |
|
|
2014
Q1 | $2.99M | Buy |
50,831
+32,863
| +183% | +$1.93M | 0.08% | 81 |
|
|
2013
Q4 | $916K | Buy |
+17,968
| New | +$916K | 0.03% | 127 |
|